SIGN UP

November 9, 2023 02:41 PM ESTUpdated 05:04 PM

Otsuka TV and banner ads for Rexulti draw rebuke from FDA watchdog

Beth Snyder Bulik

Senior Editor

Otsuka is the latest pharma in a week to receive a violation letter from FDA’s drug promotion police. Its Rexulti TV commercial and a banner …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Pfizer’s RSV vaccine has 90% efficacy against severe respiratory disease

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Patient dies in Neurogene's Rett syndrome study

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

sponsored

Are programs with compounded GLP-1s safe for your population?